Clinigen
Clinigen finalises acquisition of SSI Strategy
London, UK – 21 November 2025 – Clinigen, the global pathfinder accelerating patient access to critical medicines across the lifecycle, today confirmed the close of its acquisition of SSI Strategy, a trusted strategic consulting partner to biotech innovators. The completion of this transaction brings together SSI’s renowned strategic advisory depth, established U.S. and European footprint,...
Clinigen to Acquire SSI Strategy, Charting a Seamless Path from Clinical Strategy to Global Commercialisation for Biotech Innovators
29 September 2025 -- London, UK -- Clinigen, the global pathfinder accelerating patient access to critical medicines across the lifecycle, today announced it has entered into a definitive agreement to acquire SSI Strategy, a trusted strategic consulting partner to biotech innovators. The transaction, subject to customary closing conditions, is expected to close before the end...
Clinigen collaborates with Servier to expand access to specialised oncology and haematology medicines in South Africa
17 March 2025 -- London, UK -- Clinigen, the global speciality pharmaceutical services group, today announced that Equity Pharmaceuticals, part of the Clinigen Group, has entered into a new collaboration with Servier, an independent global pharmaceutical group, to enhance patient access to oncology and haematology medicines in South Africa. Through this new agreement, Clinigen holds...
Clinigen Announces Strategic Partnership with Tepsivo
Expanding Client Choice with AI-Powered Pharmacovigilance Solutions 27 January 2025 -- London, UK -- Clinigen, the global specialist pharmaceutical services company, today announced a strategic partnership with Tepsivo, a pioneering global digital Pharmacovigilance (PV) services provider. As part of the partnership, Clinigen has acquired a minority stake in Tepsivo. At the heart of Tepsivo’s offering is...
Clinigen appoints Fernando Ballester as Chief Financial Officer
2 July 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces the appointment of Fernando Ballester as chief financial officer (CFO), effective 1 August 2024. Fernando, who has a background in audit and financial planning and analysis, joins Clinigen with an impressive track record. Fernando Ballester Fernando has held a number...
Clinigen acquires boutique market access consultancy Ascenian to accelerate access to lifesaving treatments
6 June 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces the acquisition of Ascenian, a boutique global market access consultancy. Together the combined companies will continue to accelerate access to life-saving treatments, delivering innovative therapies to patients faster. This acquisition signifies a significant milestone in Clinigen’s ongoing evolution towards becoming...
Clinigen boosts senior team with three strategic hires
12 March 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces three strategic appointments to advance its transformation into a world leading pharma services company: Nihad Hasagic, senior vice president, Strategic Initiatives Alex Johnson, chief transformation officer Axel Degremont, senior vice president, Commercial. Nihad Hasagic Nihad Hasagic joins as SVP Strategic...
Clinigen launches ‘What is Possible?’ campaign to accelerate access to medicines on Rare Disease Day
With over 7,000 rare diseases that impact over 300 million people globally, just 5% of rare diseases have a licensed treatment 29 February 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today launched a new campaign called ‘What is Possible?’ to help empower patients and medical professionals to ask what more is...
